Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis
Benedikt Simbrunner1,2,3,4,5, Lukas Hartl1,2, Mathias Jachs1,2, David J.M. Bauer1,2, Bernhard Scheiner1,2, Benedikt Silvester Hofer1,2,3, Albert Friedrich Stättermayer1, Rodrig Marculescu6, Michael Trauner1, Mattias Mandorfer1,2, Thomas Reiberger1,2,3,4,5
1Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
2Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
3Christian Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria
4Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD), Vienna, Austria
5CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
6Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria